A Specific Method for the Measurement of Tacrolimus in Human Whole Blood by Liquid Chromatography/Tandem Mass Spectrometry
Authors:
- Janice SimpsonJSJanice Simpson
- Hoda I. AboleneenHAHoda I. Aboleneen
- 1 August 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 19 (4) , 470-476
Abstract
Tacrolimus (FK 506) measurement by immunoassays in clinical samples of organ transplant patients often lacks a specific reference method. A method combining liquid chromatography (LC) with tandem mass spectrometry (MS/MS) was developed to quantify tacrolimus in whole blood. Liquid-liquid extraction was performed on 1 ml of sample before narrow-bore LC/MS/MS analysis. Ascomycin was used as an internal standard. The standard curve was composed of seven points ranging from 1 to 50 µg/l (average r 2 = 0.9999). Limits of detection and quantitation were 0.25 and 0.75 µg/l, respectively. Imprecision was <5% across the therapeutic range. Tacrolimus recovery averaged 62%. The most abundant metabolites detected in clinical samples were 13-O- and 15-O- demethyl tacrolimus. This method was used in a comparison study with a microparticle enzyme immunoassay (MEIA): MEIA = 1.03 LC/MS/MS - 0.084 (µg/l), (Sy/x = 1.43), r 2 = 0.933. With its high sensitivity and specificity, this LC/MS/MS method presents a good reference method for immunoassay evaluation as well as a valuable tool for metabolism studies.Keywords
This publication has 17 references indexed in Scilit:
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- Simplified High-Performance Liquid Chromatography-Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross-Validation with Microparticle Enzyme ImmunoassayTherapeutic Drug Monitoring, 1995
- 190 EVALUATION OF THE NEW PRO-TRACR TACROLIMUS MONOCLONAL WHOLE BLOOD ELISA FOR MONITORING OF TACROLIMUS LEVELS IN PATIENTS AFTER KIDNEY, HEART AND LIVER TRANSPLANTTherapeutic Drug Monitoring, 1995
- Determination of the immunosuppressive drug tacrolimus in its dosage forms by high-performance liquid chromatographyChromatographia, 1995
- Isolation and identification of a FK-506 C36–C37 dihydrodiol from erythromycin-induced rabbit liver microsomesJournal of Pharmaceutical and Biomedical Analysis, 1994
- Isolation and identification by FAB mass spectrometry and NMR spectroscopy of a demethylated metabolite of FK506 from erythromycin-induced rabbit liver microsomesPharmaceutica Acta Helvetiae, 1993
- FK506 MeasurementTherapeutic Drug Monitoring, 1993
- THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVERTransplantation, 1991
- Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparationsClinical Biochemistry, 1991
- Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1990